P504S: A new molecular marker for the detection of prostate carcinoma

American Journal of Surgical Pathology

Volumn 25, Issue 11, 2001, Pages 1397-1404

  Jiang, Zhong ^a   Woda, Bruce A ^a   Rock, Kenneth L ^a   Xu, Yingdan ^a   Savas, Lou ^a   Khan, Ashraf ^a   Pihan, German ^a   Cai, Feng ^b   Babcook, John S ^c   Rathanaswami, Palaniswami ^c   Reed, Steven G ^b   Xu, Jiangchun ^b   Fanger, Gary R ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b GLAXOSMITHKLINE   (United States)

^c Abgenix Biopharma Inc   (Canada)

Author keywords

Immunocytochemistry; P504S; Prostate carcinoma

Indexed keywords

COMPLEMENTARY DNA; CYTOPLASM PROTEIN; PROTEIN P504S; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; CELL HYPERPLASIA; CONTROLLED STUDY; DNA LIBRARY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATECTOMY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TRANSURETHRAL RESECTION;

ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CARCINOMA; HUMANS; IMMUNOENZYME TECHNIQUES; KERATINS; MALE; MOLECULAR WEIGHT; PROSTATE; PROSTATIC NEOPLASMS; RACEMASES AND EPIMERASES; TUMOR MARKERS, BIOLOGICAL;

EID: 0034765524     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200111000-00007     Document Type: Article

References (25)

1. A novel strategy for generating monoclonal antibodies from single isolated lymphocytes producing antibodies of defined specificities
2. Monoclonal antibody PD41 recognizes an antigen restricted to prostate adenocarcinomas
3. Keratin immunoreactivity in the benign and neoplastic human prostate
4. Increasing incidence of minimal residual cancer in radical prostatectomy specimens
5. Proteins of human urine: II. Identification by two-dimensional electrophoresis of a new candidate marker for prostatic cancer
6. Pathological and clinical findings to predict tumor extent of nonpalpable (stage Tlc) prostate cancer
7. Subcellular localization and physiological role of alpha-methylacyl-coA racemase
8. Benign mimics of prostatic adenocarcinoma on needle biopsy
9. Monoclonal antibodies to human intermediate filament proteins: Distribution of filament proteins in normal human tissues
10. An evaluation of prostate specific antigen in prostatic cancer
11. Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma
12. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients
13. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen
14. Molecular characterization of the epitope in prostate and breast tumor-associated PR92 antigen
15. The utility of basal cell-specific anti-cytokeratin antibody (34βE12) in the diagnosis of prostate cancer
16. Cancer statistics, 1999
17. Prostatic acid phosphatase in 1993: Its limited clinical utility
18. Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathologic stage in 275 patients with clinically localized adenocarcinoma of the prostate
19. The clinical usefulness of prostate specific antigen: Update 1994
20. 12-Lipoxygenase, 12(S)-HETE, and cancer metastasis
21. Serum and urinary prostatic inhibin-like peptide in benign prostatic hyperplasia and carcinoma of prostate
22. p53 expression and clinical outcome in prostate cancer
23. A simplified purification procedure for human prostate antigen
24. A novel prostate carcinoma-associated glycoprotein complex (PAC) recognized by monoclonal antibody TURP-27
25. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray